Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO [Phase 3]

View source ↗

Summary

Phase 3 trial of suprachoroidal triamcinolone acetonide with IVT anti-VEGF for macular edema after retinal vein occlusion was terminated; results not favorable …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• IVT anti-VEGF
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 3 | Status: TERMINATED | Results posted: 2021-04-23